Skip to main content

Peer Review reports

From: Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial

Original Submission
23 Jan 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Resubmission - Version 7
Submitted Manuscript version 7
Author responded Author comments
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
28 Jul 2015 Editorially accepted
16 Oct 2015 Article published 10.1186/s12882-015-0130-5

You can find further information about peer review here.

Back to article page